Agenus Inc. (AGEN)
NASDAQ
Closed
Aug 24, 2026
Day's Range
7.6052 wk Range
2.71Overview - AGEN - Agenus Inc.
Key Statistics
Valuation
Enterprise Value
379.41M
P/E (Trailing)
‪2.70‬
P/E (Forward)
‪-134.83‬
PEG Ratio
‪-0.02‬
Price / Sales (TTM)
‪2.74‬
Price / Book
‪-1.62‬
EV / EBITDA
‪9.34‬
Profitability
Gross Margin
‪57.24%‬
Profit Margin
‪69.34%‬
Operating Margin
‪32.71%‬
Return on Assets
‪12.53%‬
Return on Equity
‪0.03%‬
Ownership
Shares Outstanding
44.75M
Float
40.23M
Short % of Shares Outstanding
‪14.01%‬
Held by Insiders
‪6.22%‬
Held by Institutions
‪45.94%‬
Price stats
Beta
‪1.39‬
50-Day Avg
‪5.30‬
200-Day Avg
‪4.03‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
2 analysts
Average price target
‪$ 19.50‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AGEN - Agenus Inc.
Peers - AGEN - Agenus Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- AGENNASDAQAgenus Inc.364.12MMarket Cap+45.73%52-week change2.71P/E (Trailing)‪69.34%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt62.93BMarket Cap+33.08%52-week change39.69P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals Inc31.58BMarket Cap-87.93%52-week change40.23P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE29.28BMarket Cap+9.87%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.61BMarket Cap+23.98%52-week change19.38P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.15.93BMarket Cap+41.98%52-week change-21.56P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBiomarin Pharmaceutical Inc.12.91BMarket Cap+12.29%52-week change180.27P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - AGEN - Agenus Inc.
About
Agenus Inc. is a clinical-stage biotechnology company focused on immuno-oncology and the development of therapies designed to activate the immune system against cancer. The company’s current work centers on antibody-based therapeutics, immune checkpoint modulators, cell therapies, vaccines, and vaccine adjuvants,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
